IRF4 and IRF8 act in CD11c+ cells to regulate terminal differentiation of lung tissue dendritic cells

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1666-1677

  Bajanã, Sandra ^a   Turner, Sean ^a   Paul, Jinny ^a   Ainsua Enrich, Erola ^a   Kovats, Susan ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; FEMALE; GENETIC POLYMORPHISM; HAPLOINSUFFICIENCY; IRF4 GENE; IRF8 GENE; LUNG; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN; ANIMAL; C57BL MOUSE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE;

ANIMALS; ANTIGENS, CD11C; CELL DIFFERENTIATION; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84958582066     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501870     Document Type: Article

References (49)

1. Braciale, T. J., J. Sun, and T. S. Kim. 2012. Regulating the adaptive immune response to respiratory virus infection. Nat. Rev. Immunol. 12: 295-305.
2. Lambrecht, B. N., and H. Hammad. 2012. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu. Rev. Immunol. 30: 243-270.
3. Satpathy, A. T., X. Wu, J. C. Albring, and K. M. Murphy. 2012. Re(de)fining the dendritic cell lineage. Nat. Immunol. 13: 1145-1154.
4. Belz, G. T., and S. L. Nutt. 2012. Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 12: 101-113.
5. Miller, J. C., B. D. Brown, T. Shay, E. L. Gautier, V. Jojic, A. Cohain, G. Pandey, M. Leboeuf, K. G. Elpek, J. Helft, et al; Immunological Genome Consortium. 2012. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13: 888-899.
6. Schlitzer, A., N. McGovern, P. Teo, T. Zelante, K. Atarashi, D. Low, A. W. Ho, P. See, A. Shin, P. S. Wasan, et al. 2013. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38: 970-983.
7. Persson, E. K., H. Uronen-Hansson, M. Semmrich, A. Rivollier, K. Hägerbrand, J. Marsal, S. Gudjonsson, U. Hakansson, B. Reizis, K. Kotarsky, and W. W. Agace. 2013. IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38: 958-969.
8. Williams, J. W., M. Y. Tjota, B. S. Clay, B. Vander Lugt, H. S. Bandukwala, C. L. Hrusch, D. C. Decker, K. M. Blaine, B. R. Fixsen, H. Singh, et al. 2013. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat. Commun. 4: 2990.
9. Gao, Y., S. A. Nish, R. Jiang, L. Hou, P. Licona-Limón, J. S. Weinstein, H. Zhao, and R. Medzhitov. 2013. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 39: 722-732.
10. Tussiwand, R., B. Everts, G. E. Grajales-Reyes, N. M. Kretzer, A. Iwata, J. Bagaitkar, X. Wu, R. Wong, D. A. Anderson, T. L. Murphy, et al. 2015. Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity 42: 916-928.
11. Akbari, M., K. Honma, D. Kimura, M. Miyakoda, K. Kimura, T. Matsuyama, and K. Yui. 2014. IRF4 in dendritic cells inhibits IL-12 production and controls Th1 immune responses against Leishmania major. J. Immunol. 192: 2271-2279.
12. Kim, T. S., and T. J. Braciale. 2009. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One 4: e4204.
13. Edelson, B. T., W. Kc, R. Juang, M. Kohyama, L. A. Benoit, P. A. Klekotka, C. Moon, J. C. Albring, W. Ise, D. G. Michael, et al. 2010. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 207: 823-836.
14. Helft, J., B. Manicassamy, P. Guermonprez, D. Hashimoto, A. Silvin, J. Agudo, B. D. Brown, M. Schmolke, J. C. Miller, M. Leboeuf, et al. 2012. Crosspresenting CD103+ dendritic cells are protected from influenza virus infection. J. Clin. Invest. 122: 4037-4047.
15. Yu, C. I., C. Becker, Y. Wang, F. Marches, J. Helft, M. Leboeuf, E. Anguiano, S. Pourpe, K. Goller, V. Pascual, et al. 2013. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-b. Immunity 38: 818-830.
16. Ballesteros-Tato, A., B. León, F. E. Lund, and T. D. Randall. 2010. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat. Immunol. 11: 216-224.
17. Haniffa, M., A. Shin, V. Bigley, N. McGovern, P. Teo, P. See, P. S. Wasan, X. N. Wang, F. Malinarich, B. Malleret, et al. 2012. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37: 60-73.
18. Helft, J., F. Ginhoux, M. Bogunovic, and M. Merad. 2010. Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice. Immunol. Rev. 234: 55-75.
19. Murphy, K. M. 2013. Transcriptional control of dendritic cell development. Adv. Immunol. 120: 239-267.
20. Jakubzick, C., E. L. Gautier, S. L. Gibbings, D. K. Sojka, A. Schlitzer, T. E. Johnson, S. Ivanov, Q. Duan, S. Bala, T. Condon, et al. 2013. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 39: 599-610.
21. Plantinga, M., M. Guilliams, M. Vanheerswynghels, K. Deswarte, F. Branco-Madeira, W. Toussaint, L. Vanhoutte, K. Neyt, N. Killeen, B. Malissen, et al. 2013. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38: 322-335.
22. Nakano, H., T. P. Moran, K. Nakano, K. E. Gerrish, C. D. Bortner, and D. N. Cook. 2015. Complement receptor C5aR1/CD88 and dipeptidyl peptidase-4/CD26 define distinct hematopoietic lineages of dendritic cells. J. Immunol. 194: 3808-3819.
23. Tamura, T., P. Tailor, K. Yamaoka, H. J. Kong, H. Tsujimura, J. J. O'Shea, H. Singh, and K. Ozato. 2005. IFN regulatory factor-4 and-8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174: 2573-2581.
24. Suzuki, S., K. Honma, T. Matsuyama, K. Suzuki, K. Toriyama, I. Akitoyo, K. Yamamoto, T. Suematsu, M. Nakamura, K. Yui, and A. Kumatori. 2004. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha-dendritic cell development. Proc. Natl. Acad. Sci. USA 101: 8981-8986.
25. Bajanã, S., K. Roach, S. Turner, J. Paul, and S. Kovats. 2012. IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation. J. Immunol. 189: 3368-3377.
26. Becker, A. M., D. G. Michael, A. T. Satpathy, R. Sciammas, H. Singh, and D. Bhattacharya. 2012. IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood 119: 2003-2012.
27. Naik, S. H., D. Metcalf, A. van Nieuwenhuijze, I. Wicks, L. Wu, M. O'Keeffe, and K. Shortman. 2006. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7: 663-671.
28. Liu, K., G. D. Victora, T. A. Schwickert, P. Guermonprez, M. M. Meredith, K. Yao, F. F. Chu, G. J. Randolph, A. Y. Rudensky, and M. Nussenzweig. 2009. In vivo analysis of dendritic cell development and homeostasis. Science 324: 392-397.
29. Ginhoux, F., K. Liu, J. Helft, M. Bogunovic, M. Greter, D. Hashimoto, J. Price, N. Yin, J. Bromberg, S. A. Lira, et al. 2009. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206: 3115-3130.
30. Grajales-Reyes, G. E., A. Iwata, J. Albring, X. Wu, R. Tussiwand, W. Kc, N. M. Kretzer, C. G. Brisenõ, V. Durai, P. Bagadia, et al. 2015. Batf3 maintains autoactivation of Irf8 for commitment of a CD8a(+) conventional DC clonogenic progenitor. Nat. Immunol. 16: 708-717.
31. Schlitzer, A., V. Sivakamasundari, J. Chen, H. R. Sumatoh, J. Schreuder, J. Lum, B. Malleret, S. Zhang, A. Larbi, F. Zolezzi, et al. 2015. Identification of cDC1-and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. Nat. Immunol. 16: 718-728.
32. Lessard, C. J., I. Adrianto, J. A. Ice, G. B. Wiley, J. A. Kelly, S. B. Glenn, A. J. Adler, H. Li, A. Rasmussen, A. H. Williams, et al; BIOLUPUS Network; GENLES Network. 2012. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet. 90: 648-660.
33. Duffy, D. L., M. M. Iles, D. Glass, G. Zhu, J. H. Barrett, V. Höiom, Z. Z. Zhao, R. A. Sturm, N. Soranzo, C. Hammond, et al; GenoMEL. 2010. IRF4 variants have age-specific effects on nevus count and predispose to melanoma. Am. J. Hum. Genet. 87: 6-16.
34. Havelange, V., Y. Pekarsky, T. Nakamura, A. Palamarchuk, H. Alder, L. Rassenti, T. Kipps, and C. M. Croce. 2011. IRF4 mutations in chronic lymphocytic leukemia. Blood 118: 2827-2829.
35. Do, T. N., E. Ucisik-Akkaya, C. F. Davis, B. A. Morrison, and M. T. Dorak. 2010. An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males. Biochim. Biophys. Acta 1802: 292-300.
36. Hambleton, S., S. Salem, J. Bustamante, V. Bigley, S. Boisson-Dupuis, J. Azevedo, A. Fortin, M. Haniffa, L. Ceron-Gutierrez, C. M. Bacon, et al. 2011. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365: 127-138.
37. Klein, U., S. Casola, G. Cattoretti, Q. Shen, M. Lia, T. Mo, T. Ludwig, K. Rajewsky, and R. Dalla-Favera. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7: 773-782.
38. Caton, M. L., M. R. Smith-Raska, and B. Reizis. 2007. Notch-RBP-J signaling controls the homeostasis of CD8-dendritic cells in the spleen. J. Exp. Med. 204: 1653-1664.
39. Feng, J., H. Wang, D. M. Shin, M. Masiuk, C. F. Qi, and H. C. Morse, III. 2011. IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J. Immunol. 186: 1458-1466.
40. Carreras, E., S. Turner, M. B. Frank, N. Knowlton, J. Osban, M. Centola, C. G. Park, A. Simmons, J. Alberola-Ila, and S. Kovats. 2010. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood 115: 238-246.
41. Jakubzick, C., M. Bogunovic, A. J. Bonito, E. L. Kuan, M. Merad, and G. J. Randolph. 2008. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J. Exp. Med. 205: 2839-2850.
42. Schiavoni, G., F. Mattei, P. Sestili, P. Borghi, M. Venditti, H. C. Morse, III, F. Belardelli, and L. Gabriele. 2002. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J. Exp. Med. 196: 1415-1425.
43. Jakubzick, C., F. Tacke, F. Ginhoux, A. J. Wagers, N. van Rooijen, M. Mack, M. Merad, and G. J. Randolph. 2008. Blood monocyte subsets differentially give rise to CD103+ and CD103-pulmonary dendritic cell populations. J. Immunol. 180: 3019-3027.
44. Varol, C., L. Landsman, D. K. Fogg, L. Greenshtein, B. Gildor, R. Margalit, V. Kalchenko, F. Geissmann, and S. Jung. 2007. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204: 171-180.
45. Waskow, C., K. Liu, G. Darrasse-Jèze, P. Guermonprez, F. Ginhoux, M. Merad, T. Shengelia, K. Yao, and M. Nussenzweig. 2008. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9: 676-683.
46. Murphy, T. L., R. Tussiwand, and K. M. Murphy. 2013. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat. Rev. Immunol. 13: 499-509.
47. Dakic, A., L. Wu, and S. L. Nutt. 2007. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol. 28: 108-114.
48. Di Bernardo, M. C., D. Crowther-Swanepoel, P. Broderick, E. Webb, G. Sellick, R. Wild, K. Sullivan, J. Vijayakrishnan, Y. Wang, A. M. Pittman, et al. 2008. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet. 40: 1204-1210.
49. Valdez, P. A., P. J. Vithayathil, B. M. Janelsins, A. L. Shaffer, P. R. Williamson, and S. K. Datta. 2012. Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity 36: 668-679.